Lavipharm Financial Statements From 2010 to 2024
| LAVI Stock | EUR 0.71 0.01 1.39% |
Check Lavipharm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lavipharm's main balance sheet or income statement drivers, such as , as well as many indicators such as . Lavipharm financial statements analysis is a perfect complement when working with Lavipharm Valuation or Volatility modules.
Lavipharm |
Lavipharm SA Company Profit Margin Analysis
Lavipharm's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Lavipharm Profit Margin | 0.02 % |
Most of Lavipharm's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lavipharm SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Lavipharm SA has a Profit Margin of 0.0248%. This is 100.22% lower than that of the Healthcare sector and 99.84% lower than that of the Drug Manufacturers - Major industry. The profit margin for all Greece stocks is 101.95% lower than that of the firm.
Lavipharm SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Lavipharm's current stock value. Our valuation model uses many indicators to compare Lavipharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lavipharm competition to find correlations between indicators driving Lavipharm's intrinsic value. More Info.Lavipharm SA is currently regarded as number one stock in return on asset category among its peers. It also is currently regarded as number one stock in profit margin category among its peers fabricating about 0.62 of Profit Margin per Return On Asset. The ratio of Return On Asset to Profit Margin for Lavipharm SA is roughly 1.63 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lavipharm's earnings, one of the primary drivers of an investment's value.About Lavipharm Financial Statements
Lavipharm shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Lavipharm investors may analyze each financial statement separately, they are all interrelated. The changes in Lavipharm's assets and liabilities, for example, are also reflected in the revenues and expenses on on Lavipharm's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Lavipharm S.A. develops, manufactures, markets, and distributes pharmaceutical, cosmetic, and consumer health products in Greece and internationally. Lavipharm S.A. was founded in 1911 and is based in Paiania, Greece. LAVIPHARM operates under Drug Manufacturers - Major classification in Greece and is traded on Athens Stock Exchange.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Lavipharm Stock Analysis
When running Lavipharm's price analysis, check to measure Lavipharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lavipharm is operating at the current time. Most of Lavipharm's value examination focuses on studying past and present price action to predict the probability of Lavipharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lavipharm's price. Additionally, you may evaluate how the addition of Lavipharm to your portfolios can decrease your overall portfolio volatility.